Posted by laima on March 1, 2007, at 9:42:49
In reply to Re: Vyvanse - still schedule II, posted by Joe Bloe on March 1, 2007, at 0:22:27
Yes, from what I gathered from the news and business reports online, the fda simply decided an amphetamine is an amphetamine, no matter how altered, and so it's going to be schedule 2 just like all the other amphetamines. They wanted more proof, more absolute irrefutable proof that no way on earth could anyone ever ever abuse it- and per common sense that would be awfully hard to guarentee, you know? And the developer doesn't claim "never abuseable"- they claim "much less abuseable"- something like that. "Less desireable effects, less appealing to former abusers of amphetamine", something like that. (Anyone interested in their precisely exact wording can refer to their press releases, etc.) But it does sound that there was some debate or speculation about this in the industry before the decision was made-some people feeling it's a mistake, others sticking to the line.
Meanwhile, it looked like Shire is listing at least two other new meds in development for ADHD- they only have numbers, not even names yet, and are listed under "research and development" on their site. No info on what they are supposed to do.
> It's too bad this drug will be Schedule II, even with its supposed lower abuse potential. If it really does have a lower potential for abuse, then why not make picking it up at the pharmacy a little easier? It would be nice to go to the pharmacy without feeling like a criminal.
poster:laima
thread:737078
URL: http://www.dr-bob.org/babble/20070224/msgs/737301.html